article thumbnail

Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype

Bill of Health

In 2013, for instance, I published an essay titled “ A Declaration of Psychedelic Studies ,” which began with these words: “The scientific research community is in the midst of a ‘psychedelic renaissance,’ but sanctioned platforms for mainstream discussion are heavily weighted in the direction of objective scientific research.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – Spring

SQA

ANVISA’s RDC 665/2022 (link in Portuguese) replaces previous regulations, including RDC 16/2013 and IN 08/2013, and went into effect on 02 May 2022. Patients currently taking the products should consult with their doctor or healthcare provider about alternative treatment options.

FDA 75
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Confident Learned Intermediaries Defeat Warning Causation

Drug & Device Law

Further, “both doctors testified that they still prescribe [the drug] for patients with conditions similar to plaintiff’s condition.” 2013 WL 4516160, at *3 (N.M. 2013 WL 85291, at *8 (D.N.J. 2013) (no causation where prescribing physician “recommended that [plaintiff] restart [the drug] at the same dose and frequency. . .

FDA 59
article thumbnail

Unimpressed Learned Intermediaries Defeat Warning Causation

Drug & Device Law

The law presumes that licensed doctors know what they are doing. 1978), where a hypertensive patient was injured after being injected with the defendant’s drug – despite warnings that “expressly directed the doctor administering the drug to refrain from giving it to a patient with hypertension.” 2013 WL 2457950, at *8 (N.D.

Doctors 59
article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Plaintiff knew about it, too, since he signed an informed consent document mentioning it. Specifically, “it would be nonsensical to require directions for patient use for a drug that is injected into the patient by a doctor in a clinical setting.” The G/N MDL was created in 2013 and mostly settled in 2016.

FDA 105